TRAFs (tumor necrosis factor receptor [TNFR]-associated factors) bind to the cytoplasmic portion of liganded TNFRs and stimulate activation of NF-kappaB or JNK pathways. A modulator of TRAF signaling, TANK, serves as either an enhancer or an inhibitor of TRAF-mediated signaling pathways. The crystal structure of a region of TANK bound to TRAF3 has been determined and compared to a similar CD40/TRAF3 complex. TANK and CD40 bind to the same crevice on TRAF3. The recognition motif PxQxT is presented in a boomerang-like structure in TANK that is markedly different from the hairpin loop that forms in CD40 upon binding to TRAF3. Critical TANK contact residues were confirmed by mutagenesis to be required for binding to TRAF3 or TRAF2. Binding affinity, measured by isothermal titration calorimetry and competition assays, demonstrated that TANK competes with CD40 for the TRAF binding site.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0969-2126(02)00733-5DOI Listing

Publication Analysis

Top Keywords

binding traf3
8
tank
7
traf3
5
downstream regulator
4
regulator tank
4
tank binds
4
cd40
4
binds cd40
4
cd40 recognition
4
recognition site
4

Similar Publications

Article Synopsis
  • Loss-of-function mutations in the NOD2 gene are key risk factors for Crohn's disease, as NOD2 helps detect bacterial components and is vital for immune responses and intestinal health.
  • While NOD2 activation leads to weaker proinflammatory responses compared to toll-like receptors (TLRs), it is crucial for defending against pathogens and regulating immune reactions.
  • Recent findings show that NOD2 can negatively regulate TLR-induced inflammation and type I interferon responses by promoting specific molecular pathways, highlighting its importance in managing inflammatory bowel disease.
View Article and Find Full Text PDF

Background: Blume, also called Tian Ma (TM), has been used to treat stroke for centuries. However, its effects on inflammation in acute cerebral ischemic injury and underlying mechanisms involved in microglial polarization remain unknown. The present study explored the effects of the TM extract on the modulation of microglial M1/M2 polarization 2 days after transient cerebral ischemia.

View Article and Find Full Text PDF

Casein kinase 1 epsilon (CK1ε), a member of the serine/threonine protein kinase family, phosphorylates a broad range of substrates. However, its role in the development of chronic liver diseases remains elusive. This study aimed to investigate the role of CK1ε in the development and progression of metabolic dysfunction-associated steatohepatitis (MASH).

View Article and Find Full Text PDF
Article Synopsis
  • Natural killer/T cell lymphoma (NKTCL) is highly aggressive, and patients with relapsed/refractory cases have poor outcomes, with ongoing research focusing on the role of Epstein-Barr virus (EBV) in this condition.
  • The study found that LMP1, a protein associated with EBV, enhances NKTCL cell growth and survival by promoting aerobic glycolysis, which involves increased glucose uptake and lactate production, ultimately leading to reduced sensitivity to conventional treatments like gemcitabine.
  • LMP1 affects the clinical progression of NKTCL, with higher levels correlating to worse outcomes, and its mechanism involves engaging the noncanonical NF-κB pathway, suggesting potential targets for new treatments.
View Article and Find Full Text PDF

Discovery and verification of diagnostic or therapeutic biomarkers for biliary tract cancer (BTC) is challenging owing to the low prevalence of the disease. Here, we identified and investigated the clinical impact of a fusion gene, Pumilio1-tumor necrosis factor receptor-associated factor 3 (PUM1-TRAF3), caused by 1;14 chromosomal translocation in BTC. PUM1-TRAF3 was initially identified in the RNA-sequencing of five BTC surgical tissues and confirmed by fluorescence in situ hybridization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!